A Controlled Clinical Trial on The Use of a Specific Antivenom Against Envenoming by Bungarus Multicinctus

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

81

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

December 31, 2006

Study Completion Date

December 31, 2006

Conditions
Snake Bite
Interventions
DRUG

Bungarus multicinctus-candidus Antivenom

Five to ten ampoules of antivenom, depending on severity of muscle paralysis, were diluted with isotonic glucose solution to have total 50 ml and infused intravenously by electric pump during one hour. After a period of 6-8 hours, a second infusion was administered, under similar condition to the first, if no clinical improvement or adverse reaction had been noted. The patients also received supportive care such as intubation, ventilation...if necessary.

OTHER

Supportive Care

Supportive Care only (endotracheal intubation, mechanical ventilation...)

Trial Locations (1)

Unknown

Vietnam Poison Control Center, Bach Mai Hospital, HMU, Hanoi

All Listed Sponsors
collaborator

Karolinska Institutet

OTHER

collaborator

Swedish International Development Cooperation Agency (SIDA)

OTHER_GOV

lead

Hanoi Medical University

OTHER

NCT00811239 - A Controlled Clinical Trial on The Use of a Specific Antivenom Against Envenoming by Bungarus Multicinctus | Biotech Hunter | Biotech Hunter